02294nam 2200601 a 450 991022012410332120240516210422.00-8330-7646-9(CKB)2670000000232840(EBL)981579(OCoLC)804665552(SSID)ssj0000870484(PQKBManifestationID)11463549(PQKBTitleCode)TC0000870484(PQKBWorkID)10818478(PQKB)10643748(MiAaPQ)EBC981579(Au-PeEL)EBL981579(CaPaEBR)ebr10583965(OCoLC)893183697(EXLCZ)99267000000023284020120810d2012 uy 0engur|n|---|||||txtccrMedicines as a service[electronic resource] a new commercial model for big pharma in the postblockbuster world /Soeren Mattke, Lisa Klautzer, and Tewodaj Mengistu1st ed.Santa Monica, Calif. RANDc20121 online resource (12 p.)RAND Health occasional paperDescription based upon print version of record.Includes bibliographical references.Medicines as a ServiceThe pharmaceutical industry can reconfigure its considerable resources to develop innovative and meaningful business models that are based on services that improve access and adherence to prescription drugs for common chronic conditions. Such innovation beyond drug development is consistent with the core capabilities of large pharmaceutical companies and has the potential to achieve profit levels similar to those of its traditional models.Occasional paper (Rand Corporation)Pharmaceutical servicesPharmaceutical industryPharmaceutical services.Pharmaceutical industry.362.29/90941Mattke Soeren851848Klautzer Lisa924081Mengistu Tewodaj924082RAND Health.MiAaPQMiAaPQMiAaPQBOOK9910220124103321Medicines as a service2073800UNINA